Sales grew modestly year-over-year, but operating and net income declined due to higher expenses and impairment losses. The company remains optimistic for full-year growth, supported by strong domestic orders and a new mid-term plan.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.